IL-17, MMP-9 and CD23 were obviously related to TNM staging and differentiation degree of colorectal cancer, suggesting that the severity of colorectal cancer can be estimated by detecting the concentrations of IL-17, MMP-9 and CD23 in peripheral blood of patients in clinic. The gene discussed is IL17A; the disease is colorectal cancer.